Other OTC - Delayed Quote • USD
Northwest Biotherapeutics, Inc. (NWBO)
At close: April 19 at 3:59 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2019) | Next Qtr. (Jun 2019) | Current Year (2018) | Next Year (2019) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2019) | Next Qtr. (Jun 2019) | Current Year (2018) | Next Year (2019) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | -- |
| Avg. Estimate | 1.37B | 1.37B | 1.37B | -- |
| Low Estimate | 1.37B | 1.37B | 1.37B | -- |
| High Estimate | 1.37B | 1.37B | 1.37B | -- |
| Year Ago Sales | -- | -- | -- | 1.37B |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | ||||
|---|---|---|---|---|
| EPS Est. | -- | -- | -- | -- |
| EPS Actual | -- | -- | -- | -- |
| Difference | -- | -- | -- | -- |
| Surprise % | -- | -- | -- | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2019) | Next Qtr. (Jun 2019) | Current Year (2018) | Next Year (2019) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 8.88 | 0 |
| 30 Days Ago | 0 | 0 | 8.88 | 0 |
| 60 Days Ago | 0 | 0 | 8.88 | 0 |
| 90 Days Ago | 0 | 0 | 8.88 | 0 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2019) | Next Qtr. (Jun 2019) | Current Year (2018) | Next Year (2019) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | NWBO | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 1.60% |
| Next Qtr. | -- | -- | -- | 10.50% |
| Current Year | -- | -- | -- | 5.20% |
| Next Year | -- | -- | -- | 13.30% |
| Next 5 Years (per annum) | -- | -- | -- | 11.22% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
| Downgrade | Oppenheimer: Outperform to Perform | 3/12/2014 |
Related Tickers
CVM CEL-SCI Corporation
1.5600
+4.00%
ANVS Annovis Bio, Inc.
10.06
+2.13%
AVXL Anavex Life Sciences Corp.
3.7800
-0.53%
ATNM Actinium Pharmaceuticals, Inc.
6.85
+2.70%
TSOI Therapeutic Solutions International, Inc.
0.0007
0.00%
VIRI Virios Therapeutics, Inc.
0.4355
-1.76%
CDTX Cidara Therapeutics, Inc.
0.6810
-5.68%
CLDI Calidi Biotherapeutics, Inc.
0.1620
+1.25%
OTLK Outlook Therapeutics, Inc.
8.17
-1.45%
BCRX BioCryst Pharmaceuticals, Inc.
4.4300
-1.56%